Product Information
GALANTAMINE HBR 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2840 per EA under NDC 65862045860. Its NADAC has been published 548 times since Nov 28, 2013.
FDA first approved this application on Mar 29, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Galantamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862045860
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090957FDA Approved
3/29/2011
TE Code
AB
On Market Since
3/29/2011
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 4 MG TABLET has been published 548 times since Nov 28, 2013, and over the history we have for it it has declined 80.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $1.7916 (Feb 12, 2014) |
| All-time low | $0.2164 (May 22, 2024) |
| 52-week high | $0.3421 |
| 52-week low | $0.2687 |
| Median price | $0.5313 |
| Average price | $0.6973 |
| Largest weekly change | +69.4% (Jan 17, 2024) |
| Weeks tracked | 548 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2840 per EA (NDC 65862045860), effective Aug 19, 2026.
How has the price of GALANTAMINE HBR 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 4 MG TABLET has declined 80.2%. It has been tracked across 548 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 4 MG TABLET?
Since Nov 28, 2013, the NADAC for GALANTAMINE HBR 4 MG TABLET has ranged from a low of $0.2164 (May 22, 2024) to a high of $1.7916 (Feb 12, 2014), with a median of $0.5313 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 4 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GALANTAMINE HBR 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GALANTAMINE HBR 4 MG TABLET?
GALANTAMINE HBR 4 MG TABLET (NDC 65862045860) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.